Search results

Jump to navigation Jump to search

Page title matches

Page text matches

  • {{rpl|Diabetes mellitus type 2}}
    737 bytes (105 words) - 04:07, 24 September 2013
  • ...d test used to monitor the treatment of [[diabetes mellitus type 1]] and [[diabetes mellitus type 2]].
    144 bytes (19 words) - 08:39, 22 June 2008
  • {{r|Diabetes mellitus type 2}}
    214 bytes (25 words) - 14:43, 28 May 2009
  • #REDIRECT [[Diabetes mellitus type 2]]
    38 bytes (4 words) - 18:29, 19 March 2010
  • #Redirect [[Diabetes mellitus type 2]]
    38 bytes (4 words) - 11:40, 14 May 2008
  • {{r|Diabetes mellitus type 2}}
    605 bytes (75 words) - 15:56, 11 January 2010
  • {{r|Diabetes mellitus type 2}}
    524 bytes (67 words) - 15:56, 11 January 2010
  • {{r|Diabetes mellitus type 2}}
    703 bytes (90 words) - 15:57, 11 January 2010
  • ...abolic risk factors for [[vascular disease|cardiovascular disease]]s and [[Diabetes mellitus type 2|type 2 diabetes mellitus]]. The major components of metabolic syndrome x in
    629 bytes (71 words) - 11:35, 17 April 2009
  • ...f lesser risk than [[Impaired glucose tolerance]] (IGT). IFG may precede [[Diabetes mellitus type 2]] by many years. IFG is also a risk factor for mortality.<ref name="pmid175 ...ly raised [[fasting]] [[glucose]] level, but less than would qualify for [[Diabetes mellitus type 2]]. On challenging with an [[oral glucose tolerance test]], normal blood glu
    2 KB (247 words) - 16:18, 12 June 2010
  • {{r|Diabetes mellitus type 2}}
    520 bytes (65 words) - 16:52, 11 January 2010
  • '''Hyperglycemic hyperosmolar nonketotic coma''' is a complication of [[diabetes mellitus type 2]].
    663 bytes (74 words) - 08:05, 17 October 2011
  • {{r|Diabetes mellitus type 2}}
    864 bytes (108 words) - 15:56, 11 January 2010
  • ...stance]] and increased risk of cardiovascular pathology. IGT may precede [[Diabetes mellitus type 2]] by many years. IGT is also a risk factor for mortality.<ref name="pmid17
    2 KB (219 words) - 17:30, 12 June 2010
  • {{r|Diabetes mellitus type 2}}
    898 bytes (111 words) - 19:11, 11 January 2010
  • ...of its blood-pressure-lowering effect in patients with [[hypertension]], [[Diabetes mellitus type 2|type 2 diabetes]], and nephropathy."<ref name="pmid18525041">{{cite journal
    1 KB (132 words) - 01:22, 15 June 2008
  • {{r|diabetes mellitus type 2}}
    889 bytes (141 words) - 08:40, 22 June 2008
  • {{r|Diabetes mellitus type 2}}
    2 KB (192 words) - 16:55, 11 January 2010
  • {{r|Diabetes mellitus type 2}}
    176 bytes (19 words) - 08:02, 26 December 2010
  • ...' ('''UKPDS''') is a [[randomized controlled trial]] of the treatment of [[diabetes mellitus type 2]].<ref name="pmid9742976">{{cite journal |author= |title=Intensive blood-g
    3 KB (406 words) - 10:17, 12 December 2011
View (previous 20 | ) (20 | 50 | 100 | 250 | 500)